CEFIXIMA AUROBINDO 200mg tablets medication leaflet

J01DD08 cefixime • Antiinfectives for systemic use | Other beta-lactam antibacterials | Third-generation cephalosporins

Cefixime is a third-generation cephalosporin antibiotic used to treat moderate bacterial infections. It is indicated for upper respiratory tract infections (such as pharyngitis or tonsillitis), urinary tract infections, otitis media, acute bronchitis, and some gonococcal infections.

Cefixime works by inhibiting bacterial cell wall synthesis, killing the bacteria responsible for the infection. It is available in tablet, capsule, or oral suspension form and is well-tolerated by most patients.

Side effects may include nausea, diarrhea, abdominal pain, or allergic reactions. In rare cases, it can cause pseudomembranous colitis or severe hypersensitivity reactions. It is contraindicated in patients with allergies to cephalosporins or penicillins.

General data about CEFIXIMA AUROBINDO 200mg

Substance: cefixime

Date of last drug list: 01-02-2023

Commercial code: W63367003

Concentration: 200mg

Pharmaceutical form: tablets

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: APL SWIFT SERVICES (MALTA) LIMITED - MALTA

Holder: AUROBINDO PHARMA ROMANIA S.R.L. - ROMANIA

Number: 13961/2021/01

Shelf life: 2 years

Pharmaceutical forms available for cefixime

Concentrations available for cefixime

100mg, 100mg/5ml, 200mg, 400mg